We demonstrate that PDT results in a marked elevation in the activity of XO (a key enzyme that hallmarks the I/R process) in treated tumours, and show that XO inhibition attenuates the neutrophil infiltration into PDT-treated tumours and decreases tumour cure rates. The gene discussed is XDH; the disease is neoplasm.